The CDK inhibitor p21
Introduction
The cellular response to stress and DNA damage is largely controlled by the tumor suppressor p53 and its target genes. The p21 waf protein functions as a mediator of p53 activity in controlling cell growth arrest, since it is a universal cyclin-dependent kinase (CDK) inhibitor (Xiong et al., 1993) . p21 waf was ®rst discovered as a gene overexpressed in senescence (Noda et al., 1994) , a CDK2-associated protein (Harper et al., 1993) and a p53-activated gene (El-Deiry et al., 1993) . This was soon followed by the demonstration that p21 waf can be induced by several p53-independent signaling pathways which may result in growth arrest or dierentiation Harper and Elledge, 1996; Steinman et al., 1994; Halevy et al., 1995) . p53-dependent activation of p21 waf is particularly important for cell cycle arrest after DNA damage due to radiation or chemotherapy (Brugaloras et al., 1995; Deng et al., 1995) . In such cases p21 waf halts cell cycle progression, possibly providing a time window for repair of DNA damage prior to resumption of DNA replication. In addition to growth arrest the damaged cell can also undergo apoptosis; the relative contribution of apoptosis versus growth arrest to prevention of tumorigenesis may vary among dierent tissues and cell types (Hansen and Oren, 1997) . Recent studies on colon cancer in mice of p537/7 and p53+/+ background indicate that p53 may retard tumor progression by yet another mechanism based on irreversible growth arrest which may lead to senescence (Fazeli et al., 1997) and it was also shown that induced p53 expression in EJ cells was shown to promote cell senescence (Sugrue et al., 1997) . The choice between reversible growth arrest, apoptosis and senescence as a result of p53 function is under extensive study and may depend on cell type and developmental stage (Bates and Vousden, 1996) . The outcome of any of the above may be an important factor in escaping from tumorigenesis and in providing an explanation for the mechanism of p53 action as a tumor suppressor.
Although the role of p21 waf in cell growth suppression as a CDK inhibitor is well established, its function in promoting or inhibiting cytotoxic eects and apoptosis is not completely known. In several studies upregulation of p21 waf was observed in cases of p53-dependent apoptosis (Kondo et al., 1997; Waldman et al., 1996) , whereas in other cases p21 waf was found to protect cells from apoptosis or drug cytotoxicity (Poluha et al., 1996; Gorospe et al., 1996 Gorospe et al., , 1997 .
Mice de®cient in p21 waf are more sensitive to radiation than normal mice (Brugaloras et al., 1995; Wang et al., 1997) and human ®broblastic cell lines that were made de®cient for p21 waf bypass cellular senescence . Inactivation of p21 waf in colorectal cancer cells renders them prone to apoptosis (Polyak et al., 1996) . Obviously, the function of p21 waf will be better understood if studied in the absence of p53, which has many other functions besides p21
waf transactivation. Therefore, we chose the p53 de®cient human cell line H1299 in order to establish an ectopic regulatable system of p21 waf expression, using the ecdysone induction system . We studied the role of p21 waf in the control of cell growth and in protection against radiation and several anticancer drugs. We show that in this system p21 waf protects against the cytotoxic eect of radiation and doxorubicin and that overexpression of p21 waf facilitates cell senescence.
Results

Regulation of p21 waf expression by muristerone
The human lung cancer cell line H1299 was chosen to generate the p21 waf -inducible cell line because it is null for p53 due to gene truncation, it is easily transfected and was shown to be growth arrested by transfection of p21
waf (El-Deiry et al., 1993; Chedid et al., 1994; Zakut and Givol, 1995) . Figure 1a shows the expression of p21 waf in dierent selected clones after muristerone induction; Figure 1b shows the induction of p21 waf expression in clone W-65 by various concentrations of muristerone and Figure 1c depicts the time course of induction in the clone W-65 using 2 mM muristerone. The results show that although H1299 express small basal amounts of endogenous p21
waf the ectopic expression of p21 waf is not leaky. Maximum expression is obtained at 2 mM muristerone ( Figure 1b ) and higher levels of muristerone did not change the expression level of p21 waf (data not shown). The results also indicate that the p21 waf inducible system is highly responsive to muristerone, and that levels of the expression of the inducible gene are easily controlled by adding increasing amounts of muristerone to the medium. The maximum levels of p21 waf is reached 24 h after induction, although p21 waf protein can be detected already as early as 3 h after induction ( Figure 1c ). The expression level of muristerone-induced p21 waf is similar to that obtained in the temperature-sensitive cell line H1299Val135#3 (a gift from M Oren). Hence the transcriptional induction of p21 waf by the ts p53Val135 upon shifting to 328 and the p53-independent muristerone induction result in a similar p21 waf expression level ( Figure 1a ). Because our p21
waf -inducible system is in the p53 null background, it oers the opportunity to directly assess the role of p21 waf in cell cycle arrest, in promoting senescence as well as in response to genotoxic agents.
The stability of the inducible p21 waf was analysed by withdrawal of muristerone from the medium and analysing the decrease of p21 waf expression in a timedependent manner, which depends both on mRNA and protein stability. Figure 2 shows that the halflife time of p21 waf after muristerone withdrawal is 9 h which include both protein synthesis and degradation. However, in the presence of cyclohexamide which inhibits protein synthesis, the half-life time of p21 waf in H1299 cells is about 90 min consistent with recently published results (Maki and Howley, 1997) . The eect of induced p21 waf on H1299 cell growth was measured by a cell proliferation assay. Cells were cultured under the same conditions with or without muristerone for 5 days and the number of cells was counted every day. Cell growth rate was signi®cantly reduced in the presence of muristerone, whereas no eect was found on the growth rate of the parental cell line R-38 (Figure 3a) . Cell cycle analysis reveals that p21 waf induction arrested the cells primarily at the G1 phase, which increased from 45.7 ± 62.5% within 48 h in the presence of muristerone. However, the most signi®cant eect of p21 waf expression in H1299 cells is the reduction of the S phase fraction from 18.4% to 9.5% ( Figure 3b ). Cell cycle analysis was also performed with R-38 cells transfected with PIND (empty vector) treated similarly with muristerone. No signi®cant change was observed at the various time points. No increase in the number of cells with sub-G1 DNA content was observed, even in the presence of muristerone for 5 days (data not shown). Hence, p21 waf induction alone does not promote apoptosis in H1299.
We also analysed the reversibility of the growth inhibition by p21 waf using the colony inhibition assay. This was performed by seeding approximately 100 cells of clone W-65 on a 60 mm plate in either the presence or absence of muristerone for various time periods, after which the medium was replaced by normal medium and the cells were allowed to multiply and form colonies for an additional 10 days. The parental R-38 clones served as a control. As shown in Figure 4 , p21 waf induction by muristerone resulted in inhibition of colony formation even after muristerone withdrawal. The presence of muristerone for 4 days reduced by 60% the number of colonies formed after muristerone withdrawal, whereas after 10 days in the presence of ) 2.56 610 10 5 5 cells were seeded on 100 mm dish. After 24 h the medium was replaced with fresh medium containing 2 cells were seeded on 100 mm dish. After 24 h the medium was replaced with fresh medium containing 2 m mM M muristerone. Cells were harvested and prepared for cell cycle analysis at the indicated times muristerone. Cells were harvested and prepared for cell cycle analysis at the indicated times muristerone the number of colonies went down to only 13% of the control. This suggested that p21 waf , originally discovered as a senescence associated gene (Noda et al., 1994) , induces senescence in H1299 cancer cells by suppressing their ability to form colonies even after removal of muristerone. In the presence of muristerone, the majority of the cells were clearly visible as well-isolated single cells or clusters of few cells. They exhibited an increased size,¯attened shape and a morphology similar to that of senescent cells. Senescent, but not quiescent cells have been shown to express a speci®c b-galactosidase (b-Gal) with activity detected by X-gal at pH 6.0 (Dimri et al., 1995) . We therefore analysed muristerone treated H1299 W-65 cells for the expression of this senescence-speci®c marker. After 5 days in the presence of muristerone approximately 50% of the cells stained blue with X-gal at pH 6.0. In contrast, no positive staining for SA-bgal was observed in W-65 cells grown in the absence of muristerone ( Figure 5 ). The senescence eect of p21 waf and the inhibition of colony formation 10 days after removal of muristerone are consistent with the notion that p21
waf confers replicative senescence on H1299 cells. Taken together, our results indicate that p21 waf induction in the absence of p53 causes a preferential G1 arrest and a reduction in the fraction of cells at S phase, leading to irreversible growth arrest with characteristics of senescence.
Eect of p21
waf overexpression on the cellular response to g-irradiation and anti-cancer drugs Over 50% of cancers contain p53 mutations which render the protein inactive as a transcription factor and unable to transactivate p21 waf . In many cases, this inactivation of p53 leads to a decreased sensitivity to DNA damaging agents. We therefore wanted to analyse the eect of the p53-independent activation of p21
waf on the response of cells to genotoxic agents. H1299 cells are p537/7 and induction of p21 waf in such cells can provide insight into the direct eect of p21 waf on the cytotoxicity of radiation and anti-cancer drugs. First, we wished to know whether such treatment can induce p21 waf in a p53-independent manner. As seen in Figure 6 , g-irradiation or taxol did not induce p21 expression in H1299 cells. Doxorubicin, however, induced a moderate elevation in p21 waf expression, but far below that achieved by muristerone induction (Figure 6 ).
We then analysed the cytotoxic eect of irradiation, doxorubicin and taxol on H1299 in the presence or absence of muristerone-induced p21 waf . Cells were seeded at a density of 2.5610 5 per 100 mm plate. Twenty-four hours later muristerone (2 mM) was added together with either doxorubicin (0.5 mg) or taxol (12.5 nM) for 72 h. Similarly, cells were irradiated with 10 Gy (1.5 Gy/min) after addition of muristerone. Cells were harvested at 1 day intervals and subjected to FACS analysis and counting of dead cells by trypan blue uptake.
The results obtained 48 h after exposure to treatment are shown in Figure 7 . In the presence of muristerone the cytotoxic eect of radiation was markedly reduced, as re¯ected by a reduction of the dead cell fraction from 29 to 9%. This was correlated with a similar reduction in the subG1 fraction (from 26 to 7.2%). A protective eect was also exerted against doxorubicin cytotoxicity, with a reduction of the dead cell count from 14.6 to 4% and the subG1 fraction from 10.2 to 3.6%. It should be noted that doxorubicin induces also the expression of endogenous p21 waf in a p53-independent manner (Figure 6 ), which may reduce its cytotoxic ecacy. In contrast, in the case of taxol no signi®cant dierence was observed between the number of dead cells in the presence or absence of muristerone. A consistent outcome of p21 waf over expression was the increase in the G1 fraction in all cases.
Discussion
We have used the muristerone-regulated expression system in order to study the eect of p21 waf on the human lung adenocarcinoma cell line H1299. This p53-de®cient cell line was employed to analyse the eect of the p53-independent transcriptional activation of p21 waf . W-65 cells were seeded at a density of 2610 5 cells per 100 mm plate and after 12 h the medium was replaced with a medium containing either 2 mM muristerone (a) or no muristerone (b). This led to growth inhibition of the muristerone treated cells (a) due to p21 waf induction. Five days later the cells were washed, ®xed and stained with x-gal at pH6 and 378C without CO 2 for 16 h to detect senescence-associated b-gal (Dimri et al., 1995) . Cells were photographed using a Zeiss axiophot microscope. Approximately 50% of the muristerone treated cells were stained blue (a) Figure 6 Expression of p21 waf in PIND cells after g-irradiation and anti-cancer drugs treatment. Log-phase PIND cells (R-38 cells transfected with the empty vector PIND) were exposed to irradiation (10 Gy, 1.5 Gy/min) or taxol (12.5 nM) or doxorubicin (0.5 mg/ml) and after 12 h. total cell lysates were prepared and 50 mg of protein were used for Western analysis as described in Materials and methods. W-67 cells induced by 2 mM muristerone for 12 h were used as a control. M-muristerone; Ir-Irradiation; Tx-taxol; Dox-doxorubicin on cell growth and resistance to DNA damaging agents. This is particularly relevant for understanding the response of the many cancer cell types in which p53 is non-functional but expression of p21 waf can nevertheless be modulated by a variety of means. Our results demonstrate that the muristerone-regulated system is not leaky and shows rapid response to induction as well as time-dependent expression of p21 waf which can be either up or down regulated. The major eect of p21 waf overexpression is the cell growth arrest due to reduction in the number of cells in the S fraction and an increase in the G1 phase fraction. We also show that the p21 waf eect resulting in growth arrest is to a great extent irreversible leading to a senescent phenotype. The induction of senescence by p21 waf takes 4 ± 6 days ( Figure 4 ) and results in loss of colony formation capability. Previous work on overexpression of p53 in the EJ cell line and our results on overexpression of p53 in H1299 cells (Wang et al., 1998) also demonstrated that the p53-dependent growth arrest resulted in senescence (Sugrue et al., 1997) . This raised the possibility that senescence may be an important mechanism which prevents tumorigenesis and may be an alternative to apoptosis. Our results show that overexpression of p21 waf has a similar potential to that of p53 in driving cells to senescence, and suggest that perhaps p53-driven senescence may also be due to the p53-induced p21 waf expression.
Recent work on cell senescence demonstrated that p16
INK4A
, a tumor suppressor gene that is not activated by p53, also plays a major role in cell senescence (Alcorta et al., 1996) . In human ®broblasts replicative senescence is a multistep process, where p21 waf expression is elevated at the initial stages of senescence (Noda et al., 1994) and later on there is a marked elevation of p16 expression and a decrease in p21 waf expression (Alcorta et al., 1996) . This is correlated with the results of inducible p16 expression in glioma cells U-1242 MG (Uhrbom et al., 1997) . Removal of tetracyclim and induction of p16 expression in these cells resulted in reversal of the immortal phenotype and entrance into senescence as indicated by the SA-b-gal staining. Thus both p16
INK4A and p21 waf which are CDK inhibitors and control cell cycle checkpoints play a major role in cell sensecence. In the case of the glioma cells the p16-dependent senescence is somewhat reversible (Uhrbom et al., 1997) , whereas in the study reported here no regain of colony formation by W-65 cells was observed after removal of muristerone. Because of the importance of senescence as a mechanism to avoid cancer further work is required to determine the relative role of p21 waf and p16 in this process.
We next wished to examine the eect of p21 waf overexpression on the cellular response to g-irradiation and the anti-cancer drugs doxorubicin and taxol. The mechanism of action of the two drugs is dierent; doxorubicin like ionizing radiation, leads to double strand breaks of the DNA, whereas taxol causes tubulin aggregation and prevents cell division. All three agents lead to a cytotoxic eect resulting in cell death. Our results show that p21 waf protects H1299 cells against the cytotoxic eects of radiation and doxorubicin but has no signi®cant eect on taxol cytotoxicity. This highlights the possibility that some drugs, like taxol, may be more eective than others even in the presence of elevated level of p21 waf . This matter is of importance in making cancer chemotherapy decisions since many tumors contain wt p53 which may elevate p21 waf expression. It is of interest that doxorubicin has a p53-independent ability to elevate p21 waf expression and this may be one of the reasons for the relatively low cytotoxic eect of this drug in H1299 cells. The induction of p21 waf by muristerone further reduces this cytotoxicity. The anti-cytotoxic eect of p21 waf in cases of radiation and doxorubicin treatment is consistent with results with cells de®cient for p21 waf , which show increased sensitivity to radiation and various anti-cancer drugs (Brugardas et al., 1995; Waldman et al., 1996; Wouters et al., 1997) . These results are also in line with the observation that p21 waf protects against apoptosis (Gorospe et al., 1996 (Gorospe et al., , 1997 Polyak et al., 1996) and that loss of p21 waf enhances the apoptotic eect of ionising radiation . Our results are also consistent with a previous study showing that p21 waf expression increases the clonogenic survival after irradiation (Waldman et al., 1997) .
The protection from radiation or doxorubicin cytotoxicity by p21 waf on the one hand, and the promotion of apoptosis by p53 on the other hand bring up the question of the relevance of these antagonistic eects to cancer treatment, since p21 waf is Figure 7 The eect of p21 waf on the response of W-65 cells to irradiation and anti-cancer drugs. W-65 cells were seeded at 2.5610 5 cells/100 mm dish. After 24 h the medium was replaced to a medium with or without muristerone (2 mM), and the cells exposed to irradiation or taxol or doxorubicin as described in Figure 6 . After 48 h¯oating cells were collected, spun down and combined with the trypsinized adherent cells. The cells were resuspended in a total volume of 1 ml, of which 50 ml was used for trypan blue staining and dead cell counting while the rest was used for cell cycle analysis by using a Becton Dickinson FACScan ow cytometer. The percentage of cells with sub-G1 DNA content and dead cell counts are shown. Ir, g-irradiation; Doxdoxorubicin; tax-taxol. M-muristerone a mediator of the growth arrest signaling by p53. Several lines of research have demonstrated that the p53-driven apoptosis and growth arrest are due to dierent biochemical pathways (Hansen and Oren, 1997; Bates and Vousden, 1996) . Recently it was also implied that the anti-apoptotic eect of p21 waf may classify it as an`oncogene' which may enhance lymphomagenesis and that drugs which inhibit p21 waf function should be considered for cancer therapy (Deng et al., 1995) . The interpretation of our results may reconcile these possibly antagonistic views by showing that the growth arrest caused by p21 waf in certain cancer cell lines may be irreversible and lead to senescence which can result in escape from tumorigenicity. Since p21 waf can be activated through many p53-independent pathways, this may open new avenues for consideration in cancer treatment.
Materials and methods
Plasmid construction
We used the recently described ecdysone-induced system ) to achieve inducible p21 waf expression in H1299 cells. Plasmids pVgRXR, encoding the receptor subunits, PIND which contains muristerone response elements and PIND/LacZ were from Invitrogen (San Diego, CA, USA). PIND/p21
waf was prepared by cloning the 0.5 kpb BamHI/ EcoRI fragment of human p21 waf cDNA into the multiple cloning site of PIND. The ecydsone analog muristerone was from Invitrogen.
Cell line and cell culture, and transfection
The human lung adenocarcinoma cell line H1299 (Takahashi et al., 1992) was grown in RPMI medium supplemented with 10% fetal bovine serum in a 378C incubator with 5% CO 2 . Transfections were performed using the calcium phosphate method (Sambrook et al., 1989) . To generate a cell line expressing inducible p21 waf protein, a two-step procedure was used. We ®rst generated stable cell lines expressing only pVgRXR in H1299 cells. To test for clonal cell lines capable of inducing expression from the muristerone response element in PIND about 40 cell clones expressing pVgRxR were isolated, transiently transfected with PIND/lacZ and maintained in the presence of muristerone A for 24 h and then stained with X-gal. Two of the 40 clones (R-37 and R-38) were found to be the best expressors of lacZ and were used for generating the p21 waf expressing clone by transfection with PIND/p21 waf , followed by G418 selection (400 mg/ml). We previously used the same clones (R-37 and R-38) to establish a p53-inducible system in H1299 cells (Wang et al., 1998.) Western blot analysis with anti-p21 waf antibody (C-19, Santa Cruz) was employed to screen for inducible expressors. Cells were maintained under double selection with zeocin (100 mg/ml) and G418 (400 mg/ml).
Immunoblot analysis
Whole-cell extracts were prepared by lysing cells with NP40 lysis buer (150 mM NaCl, 50 mM Tris (pH 7.5), 1 mM DTT, 0.5% NP40, 25 ng/ml aprotinin, 25 ng/ml leupeptin, and 1 mM phenylmethylsulfonyl¯uoride) for 15 min on ice with occasional low speed vortex. Protein content was determined with the Bio-Rad protein assay Kit (Bio-Rad). Fifty mg total protein mixed with equal amounts of 26sample buer was boiled for 5 min and then subjected to 15% SDS/PAGE. Following electrophoresis, proteins were transferred to a nitrocellulose membrane (Schleicher and Schnell). Blots were blocked in PBS containing 0.1% Tween 20 and 2.5% non-fat milk (PBS-T-milk) for 30 min at room temperature followed by incubation with the ®rst antibody in PBS-T-milk for 2 h at room temperature then washed three times with PBS-T, and incubated with a second antibody (goat anti rabbit-Ig) conjugated to horseradish peroxidase for 1 h at room temperature. The ®lter was washed three times with PBS-T, developed by chemiluminescence (Amersham) and exposed to X-ray ®lm (Fuji) for 5 ± 60 s.
Inhibition of colony formation
Cells were seeded at a density of 100 cells per 60 mm plate and maintained in the presence or absence of muristerone A (2 mM) for varying time periods. After withdrawal of muristerone at the indicated time, cells were subsequently maintained in medium without muristerone for 10 more days. For staining, 0.5 ml of crystal violet in ethanol solution was added to 2.5 ml medium of adherent cells and after 30 min the plates were washed with water, air-dried and photographed.
Senescence-associated b-gal (SA-b-gal) staining 2610 5 cells were seeded per 100 mm plate. Cells were allowed to attach for 12 h and maintained with or without muristerone A (2 mM) for 5 days. Cells were washed with PBS and ®xed with 3% formaldehyde for 5 min at room temperature, and stained with X-gal (pH 6.0) as described (Dimri et al., 1995) .
Growth rate and cell cycle analysis
To determine the rate of cell growth, 1610 5 cells were seeded on 100 mm plate and 12 h later the medium was replaced with muristerone-containing medium and changed with the same fresh medium every 48 h. At indicated time, cells were trypsinized and collected separately from at least two plates followed by cell counts with a hemacytometer. For cell cycle analysis, 2610 5 cells were seeded per 100 mm plate. After 24 h, fresh medium with 2 mM muristerone was added to the cells. At the indicated times, cells were trypsinized, collected and ®xed with methanol for 30 min at 7208. Fixed samples were washed, resuspended in PBS containing 50 mg/ml propidium iodide (Sigma) and 50 mg/ml of RNAse. The stained cells were then analysed on a Becton Dickinson FACScan¯ow cytometer. Data were analysed using the Cell®t program.
Cells response to radiation and anti-cancer drugs
5610
5 cells were seeded on a 100 mm plate and 24 h later the medium was replaced by medium with or without muristerone (2 mM) and the cells were exposed to 0.5 mg/ml doxorubicin or 12.5 nM paclitaxel (taxol) or 10 Gy irradiation using a Co 60 source with a dose rate of 1.5 Gy/min. At dierent time points, both¯oating and adherent cells were collected and used for immunoblot or cell cycle analysis as previously described.
